Mission Bio is the developer of the Tapestri Platform which is a single-cell multi-omics platform enabling genotype and phenotype from the same cell and precise detection of heterogeneity in disease progression and treatment response. This company was founded in 2014 by Adam Abate, Adam Sciambi, Charlie Silver and Dennis Eastburn and is headquartered in San Francisco, CA. Mission Bio helps researchers and clinicians unlock single-cell biology to enable the discovery, development, and delivery of precision medicine.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
05/05/2022 | Series D | $100MM | $xx.xx | $369.43MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
44,931,098
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
08/13/2020 | Series C | $72.13MM | $xx.xx | $233.2MM | Agilent Technologies, Cota Capital, Mayfield Fund, Novo Growth, Soleus Capital | |
Price per Share
$xx.xx
Shares Outstanding
34,334,582
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Agilent Technologies, Cota Capital, Mayfield Fund, Novo Growth, Soleus Capital
|
||||||
12/13/2018 | Series B | $30.07MM | $xx.xx | $77.88MM | Agilent Technologies, Cota Capital, Lam Capital, Mayfield Fund | |
Price per Share
$xx.xx
Shares Outstanding
24,442,312
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Agilent Technologies, Cota Capital, Lam Capital, Mayfield Fund
|
||||||
10/17/2017 | Series A | $14.52MM | $xx.xx | $24.19MM | Mayfield Fund | |
Price per Share
$xx.xx
Shares Outstanding
26,192,697
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Mayfield Fund
|